Literature DB >> 20433019

Imaging evaluation in otosclerosis: single photon emission computed tomography and computed tomography.

Stefano Berrettini1, Francesca Ravecca, Duccio Volterrani, Emanuele Neri, Francesca Forli.   

Abstract

OBJECTIVES: The aim of our study was to demonstrate the utility of diphosphonate bone single photon emission computed tomography (SPECT) in diagnosing otosclerosis and to correlate the findings from SPECT with age, gender, and sensorineural hearing loss. We also evaluated the ability of high-resolution computed tomography (HR-CT) in detecting otospongiotic and otosclerotic foci and correlated the HR-CT findings with the SPECT results.
METHODS: Seventy-three subjects with surgically confirmed otosclerosis underwent SPECT, and 45 of the 73 patients also underwent HR-CT of the petrous bones.
RESULTS: In the patient sample examined in this study, SPECT demonstrated a sensitivity of 95.2% and a specificity of about 96.7%. By correlating the SPECT findings, we found an inverse relationship between bone radioactivity and age (i.e., greater disease activity in younger patients) and a direct relationship between bone radioactivity and the severity of sensorineural impairment in younger patients. In the 45 patients who also underwent HR-CT, the sensitivity of HR-CT (58%) was lower than that of SPECT, and the comparison between SPECT activity and the HR-CT findings (fenestral or retrofenestral type) demonstrated a statistically significant correlation between the morphological finding of bone demineralization (pericochlear foci) and a high uptake index.
CONCLUSIONS: The use of SPECT seems to be highly effective in differentiating normal from pathological petrous bone. It also provides a quantitative evaluation of disease activity and shows a significant correlation with bone demineralization revealed by HR-CT.

Entities:  

Mesh:

Year:  2010        PMID: 20433019     DOI: 10.1177/000348941011900402

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  4 in total

1.  3D fluid attenuated inversion recovery (FLAIR) magnetic resonance imaging at different stages of otosclerosis.

Authors:  Stefano Berrettini; Francesco Lombardo; Luca Bruschini; Annalisa Ciabotti; Canapicchi Raffaello; Francesca Forli
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-09-06       Impact factor: 2.503

2.  The radiological diagnosis of fenestral otosclerosis: the utility of histogram analysis using multidetector row CT.

Authors:  Koji Yamashita; Takashi Yoshiura; Akio Hiwatashi; Osamu Togao; Kazufumi Kikuchi; Takashi Inoguchi; Seiji Kumazawa; Hiroshi Honda
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-02-18       Impact factor: 2.503

3.  Correlation of computed tomography with histopathology in otosclerosis.

Authors:  Alicia M Quesnel; Gul Moonis; Jason Appel; Jennifer T O'Malley; Michael J McKenna; Hugh D Curtin; Saumil N Merchant
Journal:  Otol Neurotol       Date:  2013-01       Impact factor: 2.311

4.  Third-generation bisphosphonates for cochlear otosclerosis stabilizes sensorineural hearing loss in long-term follow-up.

Authors:  Taha A Jan; Aaron K Remenschneider; Christopher Halpin; Margaret Seton; Michael J McKenna; Alicia M Quesnel
Journal:  Laryngoscope Investig Otolaryngol       Date:  2017-09-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.